Colour theme
Theme
Sign in
Insider · CIK 0001619837

KKR Associates North America XI L.P.

CIK 0001619837 Name as filed on the most recent filing

Filed as KKR Associates North America XI L.P. (20)

20 transaction lines · from 20 filings · filed 2016-03-10 to 2025-06-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-06-06 BrightView Holdings, Inc.
BV
S, Open-market sale 11,600,000 disposed 14.40 167,040,000.00 Form 4, filing 0001140361-25-022081
2024-05-23 BrightView Holdings, Inc.
BV
S, Open-market sale 17,500,000 disposed 12.48 218,400,000.00 Form 4, filing 0001140361-24-027735
2021-05-13 Ingersoll Rand Inc.
IR
S, Open-market sale 14,924,081 disposed 48.57 724,862,614.17 Form 4, filing 0001140361-21-017775
2020-06-19 Ingersoll Rand Inc.
IR
S, Open-market sale 12,100,000 disposed 30.40 367,840,000.00 Form 4, filing 0001140361-20-014579
2020-06-15 BrightView Holdings, Inc.
BV
S, Open-market sale 7,785,123 disposed 13.25 103,152,879.75 Form 4, filing 0001140361-20-014069
2020-05-27 Ingersoll Rand Inc.
IR
S, Open-market sale 13,782,500 disposed 28.82 397,211,650.00 Form 4, filing 0001140361-20-012767
2019-08-12 National Vision Holdings, Inc.
EYE
S, Open-market sale 9,149,908 disposed 30.52 279,255,192.16 Form 4, filing 0001140361-19-015059
2018-11-19 National Vision Holdings, Inc.
EYE
S, Open-market sale 10,054,259 disposed 40.20 404,181,211.80 Form 4, filing 0001140361-18-043578
2018-11-02 Gardner Denver Holdings, Inc.
GDI
S, Open-market sale 20,000,000 disposed 25.66 513,200,000.00 Form 4, filing 0001140361-18-042383
2018-08-09 PRA Health Sciences, Inc.
PRAH
S, Open-market sale 6,500,000 disposed 101.01 656,565,000.00 Form 4, filing 0001140361-18-036243
2018-08-02 National Vision Holdings, Inc.
EYE
S, Open-market sale 1,742,007 disposed 38.26 66,648,142.62 Form 4, filing 0001140361-18-035614
2018-07-30 National Vision Holdings, Inc.
EYE
S, Open-market sale 11,452,321 disposed 38.26 438,158,930.07 Form 4, filing 0001140361-18-034852
2018-05-07 Gardner Denver Holdings, Inc.
GDI
S, Open-market sale 30,436,064 disposed 29.84 908,136,059.60 Form 4, filing 0001140361-18-022534
2018-03-26 National Vision Holdings, Inc.
EYE
S, Open-market sale 1,444,822 disposed 31.68 45,771,960.96 Form 4, filing 0001140361-18-015539
2018-03-19 National Vision Holdings, Inc.
EYE
S, Open-market sale 9,632,145 disposed 31.68 305,146,353.60 Form 4, filing 0001140361-18-014476
2017-11-20 Gardner Denver Holdings, Inc.
GDI
S, Open-market sale 25,250,880 disposed 26.43 667,443,885.60 Form 4, filing 0001140361-17-043681
2017-08-14 PRA Health Sciences, Inc.
PRAH
S, Open-market sale 9,500,000 disposed 74.85 711,075,000.00 Form 4, filing 0001140361-17-032439
2016-11-16 PRA Health Sciences, Inc.
PRAH
S, Open-market sale 7,500,000 disposed 55.51 416,325,000.00 Form 4, filing 0001104659-16-158132
2016-05-06 PRA Health Sciences, Inc.
PRAH
S, Open-market sale 4,907,692 disposed 46.70 229,189,216.40 Form 4, filing 0001104659-16-119782
2016-03-08 PRA Health Sciences, Inc.
PRAH
S, Open-market sale 4,829,981 disposed 42.26 204,114,997.06 Form 4, filing 0001104659-16-104258

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. KKR Associates North America XI L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001619837

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.